Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers

Bibliographic Details
Title: Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers
Authors: Weinhold, Kent J., Bukowski, Jack F., Brennan, Todd V., Noveck, Robert J., Staats, Janet S., Lin, Liwen, Stempora, Linda, Hammond, Constance, Wouters, Ann, Mojcik, Christopher F., Cheng, John, Collinge, Mark, Jesson, Michael I., Hazra, Anasuya, Biswas, Pinaki, Lan, Shuping, Clark, James D., Hodge, Jennifer A.
Source: In Clinical Immunology June 2018 191:10-20
Database: ScienceDirect
More Details
ISSN:15216616
DOI:10.1016/j.clim.2018.03.002
Published in:Clinical Immunology
Language:English